RESEARCH / PARTICIPATIONBack to the library
← Find a study
Recruiting · registry status

Experiences of monitoring Parkinson's with digital tools

Researchers are exploring benefits, difficulties and personal concerns about health-monitoring technology.

Testing a treatment or activity · Study reference: DRKS00026693

Plain-language introduction written with AI from the registry; not independently checked by a clinician. Read the original details below ↓

This registry record was last updated over six months ago, or its update date is missing. Recruitment may have changed. Confirm with the team before making plans.

Open the official registry record ↗

Follow this study

Looking for volunteers

Start (reported date)
2022-06-15

Planned dates can move. A study finishing does not tell us when a paper will be published.

No results summary has been confirmed in the registry records we imported. See connected papers below; we keep checking after recruitment ends.

Changes we have recorded
  • 2026-10-11 — recruiting

These are dates we observed a change, not necessarily the dates it happened.

Papers connected to this study

No connected paper has been found yet. The tracker checks the growing library for study identifiers and registry-linked publications.

Who can join?

Ages 18 years to 85 years · Ask the team who can join

These are starting points, not the full rules. The research team can tell you whether the study is right for your situation.

Read all the rules for taking part

Sex eligibility reported by registry: all

Inclusion criteria: Patients with a clinical diagnosis of idiopathic or atypical Parkinson's syndrome according to MDS criteria, IPS stages I - IV according to Hoehn & Yahr (in OFF-state), aged between 18 and 85 years, Duration of illness: ( = 1 ), Interest in dealing with telemedicine issues Ability to use a smartphone Exclusion criteria: IPS stage = 5 according to Hoehn & Yahr (in OFF-state), palliative status
Full study name & original research details

Official study title

Self-monitoring between empowerment and new barriers - ethical, legal, social and medical implications of mHealth technologies in the use of patients with Parkinson's Disease - mHealth_PD

Short title used by the registry

Self-monitoring between empowerment and new barriers - ethical, legal, social and medical implications of mHealth technologies in the use of patients with Parkinson's Disease

Original description

Intervention: Group 1: Both quantitative and qualitative methods will be used to record the acceptance of the technology by the patient groups. There will be two test points (T0, T1) to determine the acceptance of the technology before and after the use of the wearables. In addition, the health status of the test persons will be recorded at time T0 using standardised questionnaires. T0: Recording of the health status: UPDRS (Unified Parkinson Disease Rating Scale, Part III): Instrument to determine the progression of Parkinson's disease, Montreal cognitive Assessment Test (MoCA) Multidimensional screening test to detect cognitive impairment, Charlson Comorbidity Index (CCI): Instrument used to assess comorbidities of a total of 19 underlying diseases, Beck's depression inventory (BDI-II): The BDI is a psychological test to assess the severity of depressive symptoms, (PDQ-39): Measure of the health status and quality of life of patients with Parkinson's disease, (EQ-5D-5L): Measures the health-related quality of life of patients. This questionnaire measures the following dimensions: the ability to take care of oneself, daily activities (e.g. occupation, household, etc.), pain and physical discomfort, anxiety and dejection, PQoL: Quality of Life of Relatives (PQoL). It consists of 26 items and a 5-point scale from 0 (no problem) to 4 (extreme problems), Semi-structured interview to prospectively assess technology acceptance before the use of wearables. T1: Semistructured interview on technology acceptance after the use of wearables Primary outcome: Technology acceptance Secondary outcome: Hurdles, barriers and advantages of mHealth technologies from the participants' point of view.

Conditions reported: G20;Parkinson disease

Registry records for this study

Records are joined using registration identifiers. Titles alone do not establish that two studies are the same.

Study type
Interventional
Interventions
Group 1: Both quantitative and qualitative methods will be used to record the acceptance of the technology by the patient groups. There will be two test points (T0, T1) to determine the acceptance of the technology before and after the use of the wearables. In addition, the health status of the test persons will be recorded at time T0 using standardised questionnaires. T0: Recording of the health status: UPDRS (Unified Parkinson Disease Rating Scale, Part III): Instrument to determine the progression of Parkinson's disease, Montreal cognitive Assessment Test (MoCA) Multidimensional screening test to detect cognitive impairment, Charlson Comorbidity Index (CCI): Instrument used to assess comorbidities of a total of 19 underlying diseases, Beck's depression inventory (BDI-II): The BDI is a psychological test to assess the severity of depressive symptoms, (PDQ-39): Measure of the health status and quality of life of patients with Parkinson's disease, (EQ-5D-5L): Measures the health-related quality of life of patients. This questionnaire measures the following dimensions: the ability to take care of oneself, daily activities (e.g. occupation, household, etc.), pain and physical discomfort, anxiety and dejection, PQoL: Quality of Life of Relatives (PQoL). It consists of 26 items and a 5-point scale from 0 (no problem) to 4 (extreme problems), Semi-structured interview to prospectively assess technology acceptance before the use of wearables. T1: Semistructured interview on technology acceptance after the use of wearables
Phases
N/A
Sponsor
Universitätsklinikum Gießen und Marburg, Standort Marburg
Start date reported by registry
2022-06-15 (reported)

Registry updated: Not reported · Status last verified by the registry submitter: Not reported

Registry records retrieved 2026-10-14 (UTC). Individual records may have older updates. Recruitment and eligibility must be confirmed with the study team.

Contact the research team

Public study contacts supplied to the registry. Ask whether recruitment is still open and what participation involves.

Catharina Münte · 06421 58 65895 · catharina.muente@uni-marburg.de

Study locations

Site status can differ from overall study status. “Status not reported” means local availability needs confirmation. Remote participation and travel arrangements must be checked with the team.

Facility not reported

Germany

Status not reported

The original descriptions and participation rules come from the registry. Participation is voluntary and does not guarantee benefit.